NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

Marnix Bosch
Chief Technology Officer
NorthWest Biotherapeutics
11.40 am Immunotherapy of Brain Cancer: Past, Present and Future.

• Challenges of designing & evaluating clinical trials for
immunotherapies in the GBM field.
• Strategies to sensitize glioblastoma to immune therapies.
• Exploring immune therapy resistance in glioblastoma

why would Dr Bosch want to talk about the evaluating of clinical trials for immunotherapies in the GBM field if the trial would be still ongoing?

why would Dr Bosch be at a conference if they are still in silent time?

why would Bosch want to be talking about Exploring immune therapy resistance in glioblastoma if the trial failed? TIf it failed then there is no response right?

and why would Dr Bosch still be employed if the trial has failed weeks before January 2022?

so the trial is a success and we will learn about it this year, Im pretty sure before Nov 1 given the financial situation they have put themselves in.